ESPRITAL 45

45MG TBL FLM 30

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 23.05.2019
Interruption of marketing 19.03.2019 0016647
Manufacturing reasons 20.05.2019
Interruption of marketing 13.03.2019 0016647
Manufacturing reasons 20.05.2019
Resumption of marketing 28.01.2019
Interruption of marketing 23.11.2018 0016647
Manufacturing reasons 22.1.2019

All reports are available in the Overview.

Back to list